ArticleOncoimmunology2024

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism.

Iñaki Eguren-Santamaría et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.